Overview

Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma

Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
Study of Daily Dosing with Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects with Asthma
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
Albuterol